Lin, Hui-Ping <br/><br/>
Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.  [electronic resource] 

 -  Phytotherapy research : PTR  Jan 2012 
 - 122-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1573 
<br/><br/><label>Standard No.: </label>10.1002/ptr.3523  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biological Availability<br/>Caffeic Acids--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chromones--pharmacology<br/>Curcuma--chemistry<br/>Curcumin--pharmacology<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--pharmacology<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Morpholines--pharmacology<br/>NF-kappa B--antagonists & inhibitors<br/>Phenylethyl Alcohol--analogs & derivatives<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phytotherapy<br/>Plant Extracts--pharmacology<br/>Pyrimidines--pharmacology<br/>Quinazolines--pharmacology<br/>Receptors, Fibroblast Growth Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Somatomedins--antagonists & inhibitors<br/>Tyrphostins--pharmacology